Today, Delta Lloyd NV decides to keep it stake in Cigna Corp. (CI) to the level of $2,345,000

Today, Delta Lloyd NV decides to keep it stake in Cigna Corp. (CI) to the level of $2,345,000

Delta Lloyd NV maintained its position in Cigna Corp. (NYSE:CI) during the third quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 17,997 shares of the company’s stock at the end of the third quarter. Delta Lloyd NV’s holdings in Cigna Corp. were worth $2,345,000 as of its most recent filing with the SEC.

A number of other institutional investors have also added to or reduced their stakes in the stock. Retirement Systems of Alabama increased its stake in shares of Cigna Corp. by 76.8% in the third quarter. Retirement Systems of Alabama now owns 231,166 shares of the company’s stock valued at $30,126,000 after buying an additional 100,393 shares in the last quarter. CIBC World Markets Inc. increased its stake in shares of Cigna Corp. by 158.1% in the third quarter. CIBC World Markets Inc. now owns 9,913 shares of the company’s stock valued at $1,292,000 after buying an additional 6,072 shares in the last quarter. WASHINGTON TRUST Co purchased a new stake in shares of Cigna Corp. during the third quarter valued at $203,000. Toronto Dominion Bank increased its stake in shares of Cigna Corp. by 432.9% in the third quarter. Toronto Dominion Bank now owns 7,493 shares of the company’s stock valued at $977,000 after buying an additional 6,087 shares in the last quarter. Finally, KBC Group NV increased its stake in shares of Cigna Corp. by 20.8% in the third quarter. KBC Group NV now owns 154,789 shares of the company’s stock valued at $20,172,000 after buying an additional 26,626 shares in the last quarter. Institutional investors and hedge funds own 85.29% of the company’s stock.

Cigna Corp. (NYSE:CI) traded down 0.62% during mid-day trading on Friday, hitting $138.67. 306,140 shares of the stock were exchanged. The company has a 50 day moving average of $127.40 and a 200 day moving average of $129.17. Cigna Corp. has a 12-month low of $115.03 and a 12-month high of $148.99. The firm has a market cap of $35.60 billion, a P/E ratio of 18.84 and a beta of 0.50.

Cigna Corp. (NYSE:CI) last posted its earnings results on Thursday, November 3rd. The company reported $1.94 EPS for the quarter, beating the Zacks’ consensus estimate of $1.91 by $0.03. Cigna Corp. had a net margin of 4.87% and a return on equity of 16.17%. The company had revenue of $9.90 billion for the quarter, compared to analysts’ expectations of $4.37 billion. During the same quarter in the prior year, the company posted $2.28 earnings per share. Cigna Corp.’s revenue for the quarter was up 5.2% compared to the same quarter last year. On average, equities analysts anticipate that Cigna Corp. will post $7.98 earnings per share for the current fiscal year.

Several equities research analysts have recently weighed in on CI shares. Jefferies Group reissued a “buy” rating and issued a $149.00 target price (down previously from $153.00) on shares of Cigna Corp. in a research note on Monday, November 7th. Leerink Swann reduced their price target on shares of Cigna Corp. from $160.00 to $155.00 and set an “outperform” rating on the stock in a research note on Monday, August 1st. Evercore ISI initiated coverage on shares of Cigna Corp. in a research note on Thursday, September 22nd. They issued a “hold” rating and a $134.00 price target on the stock. William Blair reaffirmed a “buy” rating on shares of Cigna Corp. in a research note on Wednesday, August 31st. Finally, Goldman Sachs Group Inc. reaffirmed a “buy” rating and issued a $160.00 price target on shares of Cigna Corp. in a research note on Thursday, September 8th. Six equities research analysts have rated the stock with a hold rating and ten have issued a buy rating to the company. The stock presently has an average rating of “Buy” and a consensus price target of $156.00.

In other Cigna Corp. news, EVP John M. Murabito sold 58,822 shares of the company’s stock in a transaction dated Monday, November 7th. The shares were sold at an average price of $125.09, for a total value of $7,358,043.98. Following the transaction, the executive vice president now owns 115,109 shares of the company’s stock, valued at $14,398,984.81. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Also, insider Jason D. Sadler sold 4,000 shares of the company’s stock in a transaction dated Monday, October 31st. The shares were sold at an average price of $121.80, for a total transaction of $487,200.00. Following the completion of the transaction, the insider now directly owns 34,019 shares in the company, valued at approximately $4,143,514.20. The disclosure for this sale can be found here. 1.20% of the stock is currently owned by company insiders.

About Cigna Corp.

Cigna Corporation (Cigna), together with its subsidiaries, is a health services company. The Company offers medical, dental, disability, life and accident insurance and related products and services. The Company’s segments include Global Health Care, Global Supplemental Benefits, Group Disability and Life, Other Operations and Corporate.

Related posts

Leave a Comment